Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke
Comparison of 5G Mobile Stroke Unit to Standard Management by Emergency Medical Services For Acute Ischemic Stroke Treatment:A Multicenter, Prospective, Open-label, Blinded Endpoint , Week-wise Randomized, Controlled Trial
Beijing Emergency Medical Center
952 participants
Apr 25, 2025
INTERVENTIONAL
Conditions
Summary
While Mobile Stroke Units (MSUs) are considered as a relatively new model for acute stroke treatment, 5G Mobile Stroke Units (5G MSUs) have already come into service for stroke treatment in some parts of China. Since limited evidence has been found to suggest their advantages over conventional Emergency Medical Services (EMS), well-conducted clinical studies are required to further assess their effectiveness and safety. This study aims to evaluate whether 5G MSUs outperform standard management (SM) by EMS in terms of functional outcomes of acute ischemic stroke (AIS) patients within 4.5 hours after symptom onset in urban and rural areas of China.
Eligibility
Inclusion Criteria6
- History and physical/neurological examination consistent with acute stroke.
- Age≥18.
- Last seen normal within 4hr 30 min of symptom onset.
- Pre-stroke modified Rankin scale ≤3(Being able to ambulate).
- No rt-PA/TNK exclusions per guidelines, prior to CT scan or baseline labs.
- Informed consent obtained from patient (if competent) or legal representative.
Exclusion Criteria2
- Malignant or other severe primary disease with life expectancy <1 year.
- Participation in other interventional randomized clinical trials within 3 months before enrollment.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
5G MSU is a specialized stroke ambulance equipped with point of care lab, CT scanner, Telemedicine, allowing patients to receive intravenous thrombolysis.
A regular ambulance. The standard management by EMS includes Electrocardiographic(ECG)monitoring, blood glucose management, airway, respiration, and blood pressure control, complication management, intravenous access establishment and other emergency measures.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06943885